Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Grandix Pharmaceuticals Limited, was an unlisted public company incorporated on 04 April, 1996. It is classified as a public limited company and is located in , Tamil Nadu. It's authorized share capital was INR 6.00 cr and the total paid-up capital was INR 46.35 lac.
The current status of Grandix Pharmaceuticals Limited is - Amalgamated.
Read more
** All rupee values in INR crores. Based on March 2025 numbers.
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Arun Kumar Pillai | 00084845 | 19 years |
| Director | Venkataraman Subramanian Iyer | 00408092 | 17 years |
| Director | Thirukandalam Srinivasan Rangan | 02578755 | 17 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SKANRAY HEALTHCARE PRIVATE LIMITED |
Amalgamated
|
7.1 Cr | 1 | Karnataka |
| FRAXIS LIFE SCIENCES LIMITED |
Amalgamated
|
2.0 Cr | 1 | Maharashtra |
| ONESOURCE SPECIALTY PHARMA LIMITED |
Active
|
4.2 Cr | 1 | Karnataka |
| CHAYADEEP VENTURES LLP |
Active
|
1.0 L | 1 | Karnataka |
| AGNUS CAPITAL LLP |
Active
|
1.0 L | 1 | Karnataka |
| QUALICHEM REMEDIES LLP |
Active
|
1.0 L | 1 | Karnataka |
| ONESOURCE SPECIALTY PHARMA LIMITED |
Active
|
4.2 Cr | 1 | Karnataka |
| SEQUENT SCIENTIFIC LIMITED |
Amalgamated
|
4.3 Cr | 1 | Maharashtra |
| ONESOURCE SPECIALTY PHARMA LIMITED |
Active
|
11.5 Cr | 1 | Maharashtra |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED |
Active
|
44.3 Cr | 1 | Maharashtra |
| STRIDES PHARMA SCIENCE LIMITED |
Active
|
92.2 Cr | 1 | Maharashtra |
| ARCOLAB (INDIA) P.LTD. |
Amalgamated
|
1.0 L | 1 | Karnataka |
| MEDGENE PHARMACEUTICALS PRIVATE LIMITED |
Amalgamated
|
10.0 L | 2 | Karnataka |
| ARECO LEAFWARE LLP |
Active
|
50,000.0 | 1 | Karnataka |
| INSTAPILL PRIVATE LIMITED |
Active
|
18.1 Cr | 1 | Karnataka |
| GRANDIX LABORATORIES LIMITED |
Amalgamated
|
2.4 Cr | 1 | Tamil Nadu |
| GLOBAL REMEDIES LIMITED |
Amalgamated
|
10.6 Cr | 1 | Tamil Nadu |
| RUPAJAN MANAGEMENT CONSULTING PRIVATE LIMITED |
Strike Off
|
1.0 Cr | 1 | Tamil Nadu |
| QUANTUM REMEDIES PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Karnataka |
| STRIDES TECHNOLOGY AND RESEARCH PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Karnataka |
Read more
The incorporation date of GRANDIX PHARMACEUTICALS LIMITED is 04 April, 1996
The authorized share capital of GRANDIX PHARMACEUTICALS LIMITED is INR ₹ 6.0 Cr.
The paid-up capital of GRANDIX PHARMACEUTICALS LIMITED is INR ₹ 46.4 L.
The registered address of GRANDIX PHARMACEUTICALS LIMITED is 42, LOGANATHAN NAGAR100 FT ROAD, CHOOLAIMEDU CHENNAI Tamil Nadu - 600094
The CIN number of GRANDIX PHARMACEUTICALS LIMITED is U24231TN1996PLC035068.